Lupin’s arm recalls Losartan Potassium tablets in US market

16 May 2022 Evaluate

Lupin’s subsidiary -- Lupin Pharmaceuticals Inc is recalling over 33 lakh bottles of Losartan Potassium Tablets, of different strengths, in the US market. The company is also recalling close to 39 lakh bottles of Losartan Potassium and Hydrochlorothiazide tablets in the market. Both the medications are used to treat high blood pressure and heart disease.

According to the US Food and Drug Administration (USFDA), the company is recalling the affected lot due to ‘CGMP’ (current good manufacturing practices). The affected lot has been manufactured at Lupin's Pithampur-based plant in Madhya Pradesh. The lot has been distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2184.00 26.65 (1.24%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.